ACP Journal Club. The Devil is in the Details...or Not? A Primer on Individual Patient Data Meta-analysis
Overview
Authors
Affiliations
Egerup P, Lindschou J, Gluud C, Christiansen O PLoS One. 2015; 10(10):e0141588.
PMID: 26517123 PMC: 4627734. DOI: 10.1371/journal.pone.0141588.
Rodger M, Langlois N, de Vries J, Rey E, Gris J, Martinelli I Syst Rev. 2014; 3:69.
PMID: 24969227 PMC: 4094595. DOI: 10.1186/2046-4053-3-69.
Gartrell B, Ying J, Sivendran S, Boucher K, Choueiri T, Sonpavde G Target Oncol. 2013; 9(3):195-204.
PMID: 23852656 PMC: 4744485. DOI: 10.1007/s11523-013-0289-2.
Metabolic complications with the use of mTOR inhibitors for cancer therapy.
Sivendran S, Agarwal N, Gartrell B, Ying J, Boucher K, Choueiri T Cancer Treat Rev. 2013; 40(1):190-6.
PMID: 23684373 PMC: 4744486. DOI: 10.1016/j.ctrv.2013.04.005.
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis.
Douketis J, Tosetto A, Marcucci M, Baglin T, Cosmi B, Cushman M BMJ. 2011; 342:d813.
PMID: 21349898 PMC: 3044449. DOI: 10.1136/bmj.d813.